Becton Dickinson expects medtech tax to cut 3% from next year's bottom line
November 8, 2012 by MassDevice staff
Medical products maker Becton Dickinson's unveils its 4th quarter earnings and predicts that next year's earnings growth will take a 3% hit after the medical device tax shaves 2.3% off its top line.
Becton Dickinson & Co. (NYSE:BDX) is expecting the medical device tax to cut about 3% off of its 2013 earnings growth, chairman, president & CEO Vincent Forlenza said during an earnings call this week.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Breast cancer: Hologic wins FDA approval for new mammography software
Hologic wins FDA approval for its new C-View 2D imaging software for use with its 3D breast...
BRIC house of cards? Emerging markets aren't delivering on healthcare
The hallowed emerging markets in Brazil, Russia, India and China aren't generating the kind of growth...
FDA approves Bausch + Lomb's eye implant
Medical device company Bausch + Lomb won FDA approval for its Trulign Toric intraocular lens, the 1st...
Claret Medical's filter thwarts debris headed for the brain in TAVI patients, study shows
California medical device maker Claret Medical's embolic protection technology captures debris...
Report: Galt Medical's Texas plant closure means 139 layoffs
Texas-based Galt Medical Corp. is reportedly laying off 139 workers as it shutters its hometown plant...
